SURGE COMPONENTS INC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that SURGE COMPONENTS INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 30, 2025 | $36.32M | Feb 27, 2026 |
| FY2025 | Nov 30, 2024 | $31.21M | Feb 27, 2026 |
| FY2024 | Nov 30, 2023 | $36.28M | Feb 28, 2025 |
| FY2023 | Nov 30, 2022 | $51.91M | Feb 28, 2024 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 30, 2025 | $10.46M | Feb 27, 2026 |
| FY2025 | Nov 30, 2024 | $8.90M | Feb 27, 2026 |
| FY2024 | Nov 30, 2023 | $9.93M | Feb 28, 2025 |
| FY2023 | Nov 30, 2022 | $14.32M | Feb 28, 2024 |
| FY2022 | Nov 30, 2021 | $10.89M | Feb 28, 2023 |
| FY2021 | Nov 30, 2020 | $8.75M | Feb 28, 2022 |
| FY2020 | Nov 30, 2019 | $9.25M | Feb 26, 2021 |
| FY2019 | Nov 30, 2018 | $8.28M | Feb 28, 2020 |
| FY2018 | Nov 30, 2017 | $7.51M | Feb 28, 2019 |
| FY2017 | Nov 30, 2016 | $7.46M | Feb 28, 2018 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 30, 2025 | $1.14M | Feb 27, 2026 |
| FY2025 | Nov 30, 2024 | $825.7K | Feb 27, 2026 |
| FY2024 | Nov 30, 2023 | $972.1K | Feb 28, 2025 |
| FY2023 | Nov 30, 2022 | $3.74M | Feb 28, 2024 |
| FY2022 | Nov 30, 2021 | $2.51M | Feb 28, 2023 |
| FY2021 | Nov 30, 2020 | $1.52M | Feb 28, 2022 |
| FY2020 | Nov 30, 2019 | $2.03M | Feb 26, 2021 |
| FY2019 | Nov 30, 2018 | $1.96M | Feb 28, 2020 |
| FY2018 | Nov 30, 2017 | $357.5K | Feb 28, 2019 |
| FY2017 | Nov 30, 2016 | ($562.5K) | Feb 28, 2018 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 30, 2025 | $1.25M | Feb 27, 2026 |
| FY2025 | Nov 30, 2024 | $903.9K | Feb 27, 2026 |
| FY2024 | Nov 30, 2023 | $1.51M | Feb 28, 2025 |
| FY2023 | Nov 30, 2022 | $4.72M | Feb 28, 2024 |
| FY2022 | Nov 30, 2021 | $3.15M | Feb 28, 2023 |
| FY2021 | Nov 30, 2020 | $1.48M | Feb 28, 2022 |
| FY2020 | Nov 30, 2019 | $1.94M | Feb 26, 2021 |
| FY2019 | Nov 30, 2018 | $1.51M | Feb 28, 2020 |
| FY2018 | Nov 30, 2017 | $336.0K | Feb 28, 2019 |
| FY2017 | Nov 30, 2016 | ($474.6K) | Feb 28, 2018 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Nov 30, 2023 | $3.01M | Feb 28, 2024 |
| FY2023 | Nov 30, 2022 | $3.31M | Feb 28, 2024 |
| FY2022 | Nov 30, 2021 | $2.59M | Feb 28, 2023 |
| FY2021 | Nov 30, 2020 | $2.42M | Feb 28, 2022 |
| FY2020 | Nov 30, 2019 | $2.70M | Feb 26, 2021 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 30, 2025 | $916.1K | Feb 27, 2026 |
| FY2025 | Nov 30, 2024 | $1.82M | Feb 27, 2026 |
| FY2024 | Nov 30, 2023 | $2.19M | Feb 28, 2025 |
| FY2023 | Nov 30, 2022 | $2.24M | Feb 28, 2024 |
| FY2022 | Nov 30, 2021 | $2.33M | Feb 28, 2023 |
| FY2021 | Nov 30, 2020 | $1.16M | Feb 28, 2022 |
| FY2020 | Nov 30, 2019 | $1.03M | Feb 26, 2021 |
| FY2019 | Nov 30, 2018 | $1.19M | Feb 28, 2020 |
| FY2018 | Nov 30, 2017 | $665.9K | Feb 28, 2019 |
| FY2017 | Nov 30, 2016 | ($138.4K) | Feb 28, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 30, 2025 | $122.0K | Feb 27, 2026 |
| FY2025 | Nov 30, 2024 | $11.0K | Feb 27, 2026 |
| FY2024 | Nov 30, 2023 | $43.4K | Feb 28, 2025 |
| FY2023 | Nov 30, 2022 | $48.4K | Feb 28, 2024 |
| FY2022 | Nov 30, 2021 | $194.9K | Feb 28, 2023 |
| FY2021 | Nov 30, 2020 | $19.4K | Feb 28, 2022 |
| FY2020 | Nov 30, 2019 | $43.9K | Feb 26, 2021 |
| FY2019 | Nov 30, 2018 | $26.6K | Feb 28, 2020 |
| FY2018 | Nov 30, 2017 | $49.5K | Feb 28, 2019 |
| FY2017 | Nov 30, 2016 | $8.6K | Feb 28, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 30, 2025 | $27.12M | Feb 27, 2026 |
| FY2025 | Nov 30, 2024 | $25.44M | Feb 27, 2026 |
| FY2024 | Nov 30, 2023 | $24.68M | Feb 28, 2025 |
| FY2023 | Nov 30, 2022 | $24.62M | Feb 28, 2024 |
| FY2022 | Nov 30, 2021 | $21.75M | Feb 28, 2023 |
| FY2021 | Nov 30, 2020 | $17.86M | Feb 28, 2022 |
| FY2020 | Nov 30, 2019 | $13.28M | Feb 26, 2021 |
| FY2019 | Nov 30, 2018 | $12.28M | Feb 28, 2020 |
| FY2018 | Nov 30, 2017 | $11.48M | Feb 28, 2019 |
| FY2017 | Nov 30, 2016 | $16.76M | Feb 28, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 30, 2025 | $5.72M | Feb 27, 2026 |
| FY2025 | Nov 30, 2024 | $5.96M | Feb 27, 2026 |
| FY2024 | Nov 30, 2023 | $6.11M | Feb 28, 2025 |
| FY2023 | Nov 30, 2022 | $7.12M | Feb 28, 2024 |
| FY2022 | Nov 30, 2021 | $8.57M | Feb 28, 2023 |
| FY2021 | Nov 30, 2020 | $7.25M | Feb 28, 2022 |
| FY2020 | Nov 30, 2019 | $4.47M | Feb 26, 2021 |
| FY2019 | Nov 30, 2018 | $5.59M | Feb 28, 2020 |
| FY2018 | Nov 30, 2017 | $6.76M | Feb 28, 2019 |
| FY2017 | Nov 30, 2016 | $5.25M | Feb 28, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 30, 2025 | $21.40M | Feb 27, 2026 |
| FY2025 | Nov 30, 2024 | $19.49M | Feb 27, 2026 |
| FY2025 | Nov 30, 2023 | $18.57M | Feb 27, 2026 |
| FY2024 | Nov 30, 2022 | $17.50M | Feb 28, 2025 |
| FY2023 | Nov 30, 2021 | $13.18M | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | $10.60M | Feb 28, 2023 |
| FY2021 | Nov 30, 2020 | $10.60M | Feb 28, 2022 |
| FY2020 | Nov 30, 2019 | $8.81M | Feb 26, 2021 |
| FY2020 | Nov 30, 2018 | $6.69M | Feb 26, 2021 |
| FY2019 | Nov 30, 2017 | $4.71M | Feb 28, 2020 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 30, 2025 | $2.80M | Feb 27, 2026 |
| FY2025 | Nov 30, 2024 | $1.67M | Feb 27, 2026 |
| FY2024 | Nov 30, 2023 | $852.0K | Feb 28, 2025 |
| FY2023 | Nov 30, 2022 | ($115.1K) | Feb 28, 2024 |
| FY2022 | Nov 30, 2021 | ($3.85M) | Feb 28, 2023 |
| FY2021 | Nov 30, 2020 | ($6.35M) | Feb 28, 2022 |
| FY2020 | Nov 30, 2019 | ($7.86M) | Feb 26, 2021 |
| FY2019 | Nov 30, 2018 | ($9.89M) | Feb 28, 2020 |
| FY2018 | Nov 30, 2017 | ($11.85M) | Feb 28, 2019 |
| FY2017 | Nov 30, 2016 | ($12.20M) | Feb 28, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 30, 2025 | $5.33M | Feb 27, 2026 |
| FY2025 | Nov 30, 2024 | $5.63M | Feb 27, 2026 |
| FY2024 | Nov 30, 2023 | $7.63M | Feb 28, 2025 |
| FY2023 | Nov 30, 2022 | $8.69M | Feb 28, 2024 |
| FY2021 | Nov 30, 2021 | $6.51M | Feb 28, 2022 |
| FY2021 | Nov 30, 2020 | $4.39M | Feb 28, 2022 |
| FY2021 | Nov 30, 2019 | $2.74M | Feb 28, 2022 |
| FY2020 | Nov 30, 2018 | $1.76M | Feb 26, 2021 |
| FY2019 | Nov 30, 2017 | $1.09M | Feb 28, 2020 |
| FY2018 | Nov 30, 2016 | $7.12M | Feb 28, 2019 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 30, 2025 | 0 | Feb 27, 2026 |
| FY2025 | Nov 30, 2024 | 0 | Feb 27, 2026 |
| FY2024 | Nov 30, 2023 | 0 | Feb 28, 2025 |
| FY2023 | Nov 30, 2022 | 0 | Feb 28, 2024 |
| FY2022 | Nov 30, 2021 | 0 | Feb 28, 2023 |
| FY2021 | Nov 30, 2020 | 0 | Feb 28, 2022 |
| FY2020 | Nov 30, 2019 | 0 | Feb 26, 2021 |
| FY2019 | Nov 30, 2018 | 0 | Feb 28, 2020 |
| FY2018 | Nov 30, 2017 | 0 | Feb 28, 2019 |
| FY2017 | Nov 30, 2016 | 0 | Feb 28, 2018 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 30, 2025 | 0 | Feb 27, 2026 |
| FY2025 | Nov 30, 2024 | 0 | Feb 27, 2026 |
| FY2024 | Nov 30, 2023 | 0 | Feb 28, 2025 |
| FY2023 | Nov 30, 2022 | 0 | Feb 28, 2024 |
| FY2022 | Nov 30, 2021 | 0 | Feb 28, 2023 |
| FY2021 | Nov 30, 2020 | 0 | Feb 28, 2022 |
| FY2020 | Nov 30, 2019 | 0 | Feb 26, 2021 |
| FY2019 | Nov 30, 2018 | 0 | Feb 28, 2020 |
| FY2018 | Nov 30, 2017 | 0 | Feb 28, 2019 |
| FY2017 | Nov 30, 2016 | 0 | Feb 28, 2018 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 30, 2025 | 5.72M | Feb 27, 2026 |
| FY2025 | Nov 30, 2024 | 5.58M | Feb 27, 2026 |
| FY2024 | Nov 30, 2023 | 5.58M | Feb 28, 2025 |
| FY2023 | Nov 30, 2022 | 5.54M | Feb 28, 2024 |
| FY2022 | Nov 30, 2021 | 5.52M | Feb 28, 2023 |
| FY2021 | Nov 30, 2020 | 5.44M | Feb 28, 2022 |
| FY2020 | Nov 30, 2019 | 5.32M | Feb 26, 2021 |
| FY2019 | Nov 30, 2018 | 5.26M | Feb 28, 2020 |
| FY2018 | Nov 30, 2017 | 5.22M | Feb 28, 2019 |
| FY2017 | Nov 30, 2016 | 10.22M | Feb 28, 2018 |